首页> 外文会议>Nano/Micro Engineered and Molecular Systems, 2009. NEMS 2009 >Development of a novel perfusion microfluidic cell culture device for cell-based assays
【24h】

Development of a novel perfusion microfluidic cell culture device for cell-based assays

机译:用于基于细胞的测定的新型灌注微流细胞培养装置的开发

获取原文

摘要

This study reports on the development of a novel perfusion microfluidic cell culture device integrated drug delivering, fluid controlling and cell culturing functions on a two- layer PDMS chip. The device consists of an array of 6 X 6 cell culture chambers, a drug gradient generator and two control valves. Cells are physically trapped and cultured in the center of the chamber by a C-shaped dam when cells loading. Drug gradient network is able to generate 6 gradient drug concentrations to treat the culture cells. And the hydraulic valves can not only make control of the fluid flow to mimic the microenvironment of cells, but keep different kind of cells separately cultured. We have investigated the effect of the hydraulic valves on fluid control, and the chip's ability to generate a range of chemical gradient concentrations. Three kinds of Human cells (L-02, SMMC-7721 and HUVEC-2C) are grown well after three-day continuous perfusion culturing in the chip. Therefore the microfluidic cell culture device shows the potential to make significant impacts in cell-based research of high throughput drug screening, tissue engineering and clinical medicine.
机译:这项研究报告了在两层PDMS芯片上集成了药物输送,流体控制和细胞培养功能的新型灌注微流细胞培养装置的开发。该设备由6个X 6个细胞培养室阵列,一个药物梯度发生器和两个控制阀组成。当细胞加载时,细胞会被C形坝物理捕获并培养在室的中心。药物梯度网络能够产生6种梯度药物浓度来处理培养细胞。液压阀不仅可以控制流体流动以模仿细胞的微环境,而且可以分别培养不同种类的细胞。我们已经研究了液压阀对流体控制的影响,以及芯片产生一系列化学梯度浓度的能力。经过连续三天的芯片灌注培养,三种人细胞(L-02,SMMC-7721和HUVEC-2C)生长良好。因此,微流体细胞培养装置显示出对基于细胞的高通量药物筛选,组织工程和临床医学研究产生重大影响的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号